Search research articles
Contact Us
Filters
Showing results (1-10 of 360) with videos related to
Page
of 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2003
Why do we need another antiemetic? Just ask
Mark G Kris
The Oncologist
|
November 8, 2005
How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care
Mark G Kris
Lung Cancer (Amsterdam, Netherlands)
|
June 3, 2008
Foreword; challenging the 'one-size-fits-all' approach of chemotherapy and radiotherapy for patients with non-small cell lung cancer
Mark G Kris
Lung Cancer (Amsterdam, Netherlands)
|
December 14, 2002
New approaches in the treatment of non-small cell lung cancer: taxanes in the treatment of NSCLC: pathways to progress
Mark G Kris, Maurizio Tonato
CA: a Cancer Journal for Clinicians
|
July 1, 2004
Management of lung cancer in older adults
Arti Hurria, Mark G Kris
Seminars in Oncology
|
February 1, 2017
Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: An international update
Mark G Kris, Christian Manegold
Seminars in Oncology
|
August 10, 2002
Expanding horizons: an update on the use of docetaxel in non-small cell lung, ovarian, and breast cancers
Gabriel N Hortobagyi, Mark G Kris
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 11, 2013
Update: NCCN non-small cell lung cancer clinical practice guidelines
David S Ettinger, Mark G Kris
Translational Lung Cancer Research
|
May 17, 2023
Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectives
Mark G Kris, Tetsuya Mitsudomi, Solange Peters
The New England Journal of Medicine
|
July 14, 2006
EGFR mutations in small-cell lung cancers in patients who have never smoked
Maureen F Zakowski, Marc Ladanyi, Mark G Kris, et al.
Page
of 36
Search research articles
Search
Showing results (1-10 of 360) with videos related to
Sort By:
Page
of 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2003
Why do we need another antiemetic? Just ask
Mark G Kris
The Oncologist
|
November 8, 2005
How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care
Mark G Kris
Lung Cancer (Amsterdam, Netherlands)
|
June 3, 2008
Foreword; challenging the 'one-size-fits-all' approach of chemotherapy and radiotherapy for patients with non-small cell lung cancer
Mark G Kris
Lung Cancer (Amsterdam, Netherlands)
|
December 14, 2002
New approaches in the treatment of non-small cell lung cancer: taxanes in the treatment of NSCLC: pathways to progress
Mark G Kris, Maurizio Tonato
CA: a Cancer Journal for Clinicians
|
July 1, 2004
Management of lung cancer in older adults
Arti Hurria, Mark G Kris
Seminars in Oncology
|
February 1, 2017
Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: An international update
Mark G Kris, Christian Manegold
Seminars in Oncology
|
August 10, 2002
Expanding horizons: an update on the use of docetaxel in non-small cell lung, ovarian, and breast cancers
Gabriel N Hortobagyi, Mark G Kris
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 11, 2013
Update: NCCN non-small cell lung cancer clinical practice guidelines
David S Ettinger, Mark G Kris
Translational Lung Cancer Research
|
May 17, 2023
Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectives
Mark G Kris, Tetsuya Mitsudomi, Solange Peters
The New England Journal of Medicine
|
July 14, 2006
EGFR mutations in small-cell lung cancers in patients who have never smoked
Maureen F Zakowski, Marc Ladanyi, Mark G Kris, et al.
Page
of 36